Zanini M, Wulkan C

Idioma: Portugués
Referencias bibliográficas: 10
Paginas: 247-248
Archivo PDF: 121.32 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Scott AB, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 1988;3:333-5.

2. 2.Coffeld JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. En: Jankovic J, Hallet M, ed. Therapy with botulinum toxin. New York, Marcel Dekker, 1994:3-13.

3. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotin. Adv Dermatol 1997; 12:325-48.

4. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotin. In: Klein AW, ed. Tissue augmentation in clinical practice: procedures and techniques. New York: Marcel Dekker, 1998:207-36.

5. 5.Carruthers A, Kliene K, Carruthers J. Botulinum A exotin use in clinical dermatology. J Am Acad Dermatol 1996;34:788-97.

6. Matarasso SL. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg 1998;24:1249-54.

7. 7.Gartland MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (Botox): degradation impotency with storage. Otolaryngol Head Neck Surg 1993;108:135-40.

8. 8.Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment. En: Jankovic J, Hallet M, ed. Therapy with botulinum toxin. New York, Marcel Dekker, 1994:41-9.

9. 9.Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg 1998;24:1779-80.

10. Flynn TC, Carruthers A, Carruthers J. Surgical pearl: the use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol 2002; 46:931-3.